Contents

Current Drug Targets - Infectious Disorders, Volume 1 - Number 2

Rational Drug Design of DNA Oligonucleotides as HIV Inhibitors

, 1(2): 79 - 90

N. Jing and Xuejun xu


DOI: 10.2174/1568005013343173




Lipopolysaccharide as a Target for the Development of Novel Therapeutics in Gram-Negative Bacteria

, 1(2): 91 - 106

J. A. yethon and C. whitfield


DOI: 10.2174/1568005014606143




Unexploited Viral and Host Targets for the Treatment of Human Immunodeficiency Virus Type 1 Infection

, 1(2): 107 - 123

E. P. Garvey


DOI: 10.2174/1568005014606125




HIV-1 Integration as a Target for Antiretroviral Therapy: A Review

, 1(2): 133 - 149

W. pluymers, E. De Clercq and Z. Debyser


DOI: 10.2174/1568005014606044




The HCMV Chemokine Receptor US28 is a Potential Target in Vascular Disease

, 1(2): 151 - 158

D. N. Streblow, S. L. Orloff and J. A. Nelson


DOI: 10.2174/1568005014606080




1,3-beta-Glucan Synthase: A Useful Target for Antifungal Drugs

, 1(2): 159 - 169

J. Liu and M. K. Balasubramanian


DOI: 10.2174/1568005014606107




Adhesion Mechanisms of the Lyme Disease Spirochete, Borrelia burgdorferi

, 1(2): 171 - 179

J. coburn


DOI: 10.2174/1568005014606062




The Discovery of Linezolid, the First Oxazolidinone Antibacterial Agent

, 1(2): 181 - 199

C. W. Ford, G. E. Zurenko and M. R. Barbachyn


DOI: 10.2174/1568005014606099




E. Coli MurG: A Paradigm for a Superfamily of Glycosyltransferases

, 1(2): 201 - 213

S. Ha, B. Gross and S. walker


DOI: 10.2174/1568005014606116




Overcoming Bacterial Resistance by Dual Target Inhibition: The Case of Streptogramins

, 1(2): 215 - 225

A. Canu and R. Leclercq


DOI: 10.2174/1568005014606152




Antifibrogenic Therapies in Chronic HCV Infection

, 1(2): 227 - 240

I. shimizu


DOI: 10.2174/1568005014606053




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science